The MedAdvisor (ASX:MDR) share price is lifting today. Here’s why

The MedAdvisor (ASX: MDR) share price is surging today after a health program deal was extended. Here are the details.
The post The MedAdvisor (ASX:MDR) share price is lifting today. Here’s why appeared first on The Motley Fool Australia. –

Three pills with faces showing sad to happy, indicating a rising share price for an ASX pharmaceutical company

The MedAdvisor Ltd (ASX: MDR) share price is soaring today after the company announced an extension of a health program deal.

In early afternoon trade, the medication management platform provider’s shares are swapping hands for 33.5 cents, up 3.8% after reaching an intraday high of 35 cents.

Let’s take a closer look at what’s driving the MedAdvisor share price higher today.

Health program extension

In its release, MedAdvisor advised that a global pharmaceutical company has extended its United States health program deal for an estimated additional 3 months. The contract extension is expected to generate US$4.7 million in revenue for MedAdvisor.

This follows a previously signed agreement that saw MedAdvisor provide its platform to the pharmaceutical company over a 5-month period. That deal alone was worth US$3.7 million.

Although MedAdvisor did not specify which company was behind the contract extension, it is believed to be from a top 10 global pharmaceutical company.

Words from management

MedAdvisor CEO and managing director Robert Read hailed the company’s success, saying:

We’re delighted to have another health program extended in the US market. These health programs deliver tailored content specifically to the right patients based on advanced algorithms and are designed to ensure they are aware of the benefits of certain medications or vaccines.

MedAdvisor continues to expand its global deal pipeline as it establishes scalable revenue streams both domestically and abroad. Our US pipeline of 2021 deals is ahead of this time last year.

MedAdvisor share price snapshot

The MedAdvisor share price hasn’t moved much over the last 12 months, rising a modest 6%. Its year-to-date performance, however, is marginally down around 2%.

MedAdvisor shares reached a multi-year high of 66.5 cents in late May 2020 before treading lower.

Based on valuation grounds, the company commands a market capitalisation of more than $124 million, with 359.4 million shares outstanding.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of MedAdvisor. The Motley Fool Australia has recommended MedAdvisor. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post The MedAdvisor (ASX:MDR) share price is lifting today. Here’s why appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!